BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 5071601)

  • 1. [Allopurinol induced electrolyte and metabolism changes in the urine of patients with kidney stones].
    Schwille PO; Jügelt U; Sigel A
    Urologe A; 1972 Jul; 11(4):185-9. PubMed ID: 5071601
    [No Abstract]   [Full Text] [Related]  

  • 2. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi.
    Thomas WC
    Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct titrimetric determination of uric acid separately and in urine of patients containing stone.
    Shyam H; Saxena OC
    Ital J Biochem; 1973; 22(2):65-73. PubMed ID: 4771416
    [No Abstract]   [Full Text] [Related]  

  • 5. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrolyte excretion of patients with kidney stones].
    Götz F; Váry L; Kelemen Z
    Z Urol Nephrol; 1969 Jan; 62(1):23-8. PubMed ID: 4247405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal electrolyte changes by allopurinol. A contribution in the prophylaxis of oxalic acid stones (author's transl)].
    Garke P; Terhorst B
    Urologe A; 1974 Jul; 13(4 Pt A):166-7. PubMed ID: 4212796
    [No Abstract]   [Full Text] [Related]  

  • 8. Urine composition in patients with renal stone disease during treatment with allopurinol.
    Tiselius HG; Larsson L
    Scand J Urol Nephrol; 1980; 14(1):65-71. PubMed ID: 7375845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of probenecid and thiazides and their combination on the urinary excretion of electrolytes and on acid-base equilibrium.
    Garcia DA; Yendt ER
    Can Med Assoc J; 1970 Sep; 103(5):473-83. PubMed ID: 5469617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of thiazide diuretics on carbohydrate-induced calciuria in patients with recurrent renal calculi.
    Wilson DR; Siddiqui AA; Ehrig U
    J Lab Clin Med; 1975 Jul; 86(1):118-25. PubMed ID: 239075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium, magnesium, phosphorus, potassium and sodium excretion in urine in patients with kidney stones and their relation to the kind of stone].
    Schneider HJ
    Z Urol Nephrol; 1969 Feb; 62(2):123-34. PubMed ID: 5384514
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of renal stones may be prevented by restoring normal urinary composition.
    Pak CY
    Proc Eur Dial Transplant Assoc; 1983; 20():371-85. PubMed ID: 6361751
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B; Al-Khader A; Cohen SL; Kasidas GP; Krywawych S; Edgar L; Rose GA
    Proc Eur Dial Transplant Assoc; 1981; 18():556-60. PubMed ID: 6276882
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary composition in calcific nephrolithiasis.
    Isaacson LC
    Invest Urol; 1969 Jan; 6(4):356-63. PubMed ID: 5773520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of the recurrence of urinary lithiasis: mineral waters with high or low calcium content?].
    Sommariva M; Rigatti P; Viola MR
    Minerva Med; 1987 Dec; 78(24):1823-9. PubMed ID: 3431728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative treatment of kidney calculi].
    Dworschak W; Haschek H
    Med Klin; 1969 Feb; 64(7):273-8. PubMed ID: 5769478
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight, age and coefficients of variation in renal solute excretion.
    Perry GM; Scheinman SJ; Asplin JR
    Nephron Physiol; 2012; 122(1-2):13-8. PubMed ID: 23595094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variations in calcium phosphate and calcium oxalate activity products in normal and stone-forming urines.
    Hodgkinson A; Marshall RW; Cochran M
    Isr J Med Sci; 1971 Nov; 7(11):1230-4. PubMed ID: 5159604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.